India to Brazil: Carfilzomib Export Trade Route

The India to Brazil Carfilzomib corridor is one of India's established pharmaceutical export routes, with 28 shipments documented worth a combined $22.3K USD. The route is dominated by SPECIALITY MEDICINES PRIVATE LIMITED, which alone accounts for roughly 54% of all export value, reflecting the consolidated nature of India's carfilzomib manufacturing sector.

Across 7 active suppliers, the average shipment value stands at $796 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with carfilzomib's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 24.8%, placing it at rank #4 among India's top carfilzomib export destinations globally.

On the import side, key buyers of Indian carfilzomib in Brazil include `TO THE ORDER OF, PATIENT: JOSE BATISTA PACIFICO, TO THE ORDER OF and 11 others. `TO THE ORDER OF is the single largest importer with 1 shipments valued at $6.6K USD.

India's carfilzomib exports to Brazil are driven primarily by a handful of large-scale manufacturers. SPECIALITY MEDICINES PRIVATE LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in Brazil benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — SPECIALITY MEDICINES PRIVATE LIMITED, SPECIALITY MEDICINES LIMITED, JPC GLOBAL — together account for 89% of total trade value on this route. The average shipment value of $796 USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as harmless pharmaceutical medicines for human use- carfilzomib for injection krpolis, batch no: 1156844 (kyprolis 60mg injset and harmless pharmaceutical medicines for human use- carfilzomib for injection krpolis,set, suggesting that buyers in Brazil tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, `TO THE ORDER OF is the largest importer with 1 shipments worth $6.6K USD — representing 30% of all carfilzomib imports from India on this route. A total of 14 buyers are active on this corridor.